Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001396580 | SCV001598313 | likely benign | Tuberous sclerosis 2 | 2024-12-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456621 | SCV002617484 | likely benign | Hereditary cancer-predisposing syndrome | 2021-01-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004704523 | SCV005216965 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Ce |
RCV004704523 | SCV005432304 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |